RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Pablo Vivas to Receptor, Cannabinoid, CB2

Back to Details
This is a "connection" page, showing publications Pablo Vivas has written about Receptor, Cannabinoid, CB2.
Pablo Vivas
Connection Strength
0.080
Receptor, Cannabinoid, CB2
  1. Naguib M, Diaz P, Xu JJ, Astruc-Diaz F, Craig S, Vivas-Mejia P, Brown DL. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models. Br J Pharmacol. 2008 Dec; 155(7):1104-16.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support